CLINICAL CHEMISTRY CONFERENCE

8 February 2018

5.75 CME Points

Za’abeel Hall 6, Conference Room 1

Overview

To further develop a thorough understanding of laboratory operations, instrumentation and test availability, this Clinical Chemistry Conference at MEDLAB will provide laboratory professionals latest solutions for better quality and turnaround time and technology usage.

Key topics

  • Results in thyroid function tests
  • Role of the lab in chronic kidney disease classification
  • Microscopic review of urinalysis
  • Interference in immunoassays
  • Lab automation for performance and productivity

Benefits of attending

  • Identify latest updates in assays
  • Discuss analytical and clinical applications of high sensitive troponin
  • Describe advances in urinalysis
  • Appraise quality control and automation in clinical laboratory

Chair: Dr Najat Rashid, Chief of Laboratory services, SKMCA, Ministry of Presidential Affair, Dubai, UAE
Activity Director: Dr Fadi W. Abdul –Karim,
Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics | Beckman Coulter | Siemens Healthineers

Supported by:

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics
Beckman Coulter
Siemens Healthineers

09:20

Opening remarks by the chair

Dr Najat Rashid, Chief of Laboratory services, SKMCA, Ministry of Presidential Affair,
Dubai, UAE

Session 1

Moderator: Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

09:30

Proficiency testing: What are we doing right and what are we doing wrong?

Dr Sushma Umrao, Specialist, Clinical Pathology, Danat Al Emarat Hospital, Abu Dhabi, UAE

10:00

Prime time in urinalysis: Kidney damage detection with affordable microalbumin screening

Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Ghent, Belgium

10:30

Biomarkers of cachexia: Status and perspective

Prof Damien Gruson, Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium

11:00 Coffee Break


Session 2

Moderator: Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

11:30

Autoimmun nephropathy

Dr Wolfgang Schlumberger, Vice Chairman, EuroImmun, Lubeck, Germany

12:00

The role of proficiency testing and accuracy-based surveys

Dr R. Bruce Williams, President,College of American Pathologists' (CAP); Founding member, Laboratory Director, The Delta Pathology Group, Lafayette, Louisiana, USA

12:30 Lunch Break


Session 3

Moderator: Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

13:30

The role of inflammatory marker calprotectin in diagnosis and follow up of inflammatory bowel disease

Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

14:00

Novel acute and chronic kidney diseases biomarkers

Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

15:00 Coffee Break


Session 4

15:30

Tumor marker: from bench to bedside

Dr Buthaina Saif Al-Bahri, Consultant, Nizwa Hospital, Muscat, Oman

16:00 End of conference

Supported by:

ACTIVITY DIRECTORS:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA


PLANNING COMMITTEE:

Dr Najat Rashid, Chief of Laboratory services, SKMCA, Ministry of Presidential Affair, Dubai, UAE


SPEAKER FACULTY:

Dr Buthaina Saif Al-Bahri, Consultant, Nizwa Hospital, Muscat, Oman

Prof Damien Gruson, Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium

Dr Joris R Delanghe, Professor, Clinical Chemistry, Ghent University, Ghent, Belgium

Dr R. Bruce Williams, President, College of American Pathologists' (CAP); Founding member, Laboratory Director, The Delta Pathology Group, Lafayette, Louisiana, USA

Dr Sushma Umrao, Specialist, Clinical Pathology, Danat Al Emarat Hospital, Abu Dhabi, UAE

Dr Tony Avades, Consultant Chemical Pathology & Lipids, Academic Lead for Pathology Plymouth Medical School, Derriford Combined Laboratory, Plymouth Hospital NHS Trust, London, UK

Dr Wolfgang Schlumberger, Vice Chairman, EuroImmun, Lubeck, Germany

Supported by: